| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aton Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0068 |
| 52 Week High | €0.052 |
| 52 Week Low | €0.0027 |
| Beta | 0 |
| 11 Month Change | 70.00% |
| 3 Month Change | -6.85% |
| 1 Year Change | -86.45% |
| 33 Year Change | -96.32% |
| 5 Year Change | n/a |
| Change since IPO | -93.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3HB | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 38.8% | -1.0% | -0.7% |
| 1Y | -86.5% | -19.5% | 1.4% |
Return vs Industry: 3HB underperformed the German Biotechs industry which returned -19.5% over the past year.
Return vs Market: 3HB underperformed the German Market which returned 1.4% over the past year.
Price Volatility
| 3HB volatility | |
|---|---|
| 3HB Average Weekly Movement | 136.1% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3HB's share price has been volatile over the past 3 months.
Volatility Over Time: 3HB's weekly volatility has increased from 74% to 136% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.aton-group.com |
Aton operates as a bioscience company in France. It engages in drug development preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company was founded in 1998 and is headquartered in Strasbourg, France.
Aton Fundamentals Summary
| 3HB fundamental statistics | |
|---|---|
| Market cap | €9.58m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 3HB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3HB income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 3HB perform over the long term?
See historical performance and comparison